Biosysen Limited
HHKEX:13550.20
HKD
-0.01
(-6.19%)
ISIN
KYG5458R1175
CUSIP
G5458R117
Return %
Stock
S&P 500
1Y
151.97
14.20
3Y
36.67
81.12
5Y
-16.52
68.34
Capital Structure
HKD
•
in mil. unless spec.Working Capital
HKD
•
in mil. unless spec.Growth Rates
HKD
•
in mil. unless spec.Semi-annual Revenue
HKD
•
in mil. unless spec.Semi-annual Earnings Per Share
HKD
•
in mil. unless spec.Semi-annual Dividends Per Share
HKD
•
in mil. unless spec.Company Description
- CEO
- Mei Zhonghua
- Full Time Employees
- 94
- Sector
- Consumer services
- Industry
- Hotels/Resorts/Cruise lines
- Address
- Lee Garden Two Hong Kong Hong Kong
- IPO Date
- Jul 15, 2011
- Website
- legend-strategy.com
- Similar Companies
- Business
- Legend Strategy International Holdings Group Company Limited (1355.HK), an investment holding company incorporated in the Cayman Islands in 2011 and listed on the Main Board of The Stock Exchange of Hong Kong Limited, engages principally in accommodation operations and consultancy services in the People's Republic of China; it operates five leased branches including Welcome Inn Nanshan and Baoan in Shenzhen, Hazens East Resort in Huizhou, Chengdu Hotel near Tianfu Square, and Wuhan Hotel in East-West Lake District, offering a total of 648 rooms with amenities such as conference facilities, green renovations, and proximity to transportation hubs, tourist sites, and commercial areas; the company provides accommodation consultancy including market research, investment feasibility analysis, construction and design consultations, pre-opening management, operational revamps, and corporate training for hotels, guesthouses, hostels, service apartments, elderly apartments, homestays, and dormitories; it offers franchise co-operation management services granting brand usage rights, marketing support, operational training, on-site supervision, and standardized quality controls; accommodation outsourcing management encompasses cleaning, guest room preparation, inventory supply, and tailored personnel, quality, and service management for various lodging types; property facilities management and sales of healthcare and beauty products, including bioregenerative, collagen, and anti-aging skincare items, form additional core offerings; other activities include money lending since obtaining a license in 2017 and exploration of elderly care services with medical support for business diversification. Headquartered at Suite 1702, 17/F, World-Wide House, 19 Des Voeux Road Central, Central, Hong Kong, the company operates primarily in southern and central China targeting budget travelers, business guests, and institutional clients, with Hehui International Development Limited as its controlling shareholder since 2018. Recent developments encompass a September 2024 private placement of 198,840,000 new shares at HK$0.063 each raising approximately HK$12.53 million to bolster the healthcare and beauty segment; a March 2025 proposed non-underwritten rights issue of up to 538,033,708 shares at HK$0.088 each aiming to raise up to HK$47.3 million gross for healthcare and beauty expansion amid net liabilities of HK$80.3 million as of June 2024 and revenue decline; insider purchases in 2025 reflecting optimism as market capitalization rose HK$15 million following a 14% share price increase; and strategic emphasis on hotel acquisitions, management contracts, internal restructuring for profitability, and entry into big health sectors to enhance economic cycle resilience and shareholder returns.